View Article

Abstract

Amoxapine, a tricyclic antidepressant that inhibits norepinephrine and serotonin reuptake, requires a simple, precise, and reliable analytical method for its estimation in pharmaceutical formulations. The present study aimed to develop and validate both a UV spectrophotometric and HPLC method for the analysis of Amoxapine in bulk dosage form. In the UV spectrophotometric method, methanol was used to prepare stock and working solutions, and the drug exhibited maximum absorbance at 252 nm when scanned over the 200–400 nm range. For the HPLC method, chromatographic separation was achieved on an Endurus C18 Classic column (100 × 4.6 mm, 3 µm) using a mobile phase of 10 mM ammonium acetate (channel A) and acetonitrile (channel B) (1:1) with gradient elution at a flow rate of 1.5 mL/min, while detection was performed at 240 nm. Amoxapine showed linearity in the range of 4–24 µg/mL for UV spectrophotometry and 0.5–2.5 µg/mL for HPLC, with a retention time of 4.162 minutes. Validation results confirmed the accuracy, precision, and reliability of both methods, making them suitable for routine quality control analysis of Amoxapine.

Keywords

Amoxapine, UV-Spectrophotometric Method, HPLC method, Analytical Method Development, Validation Parameters, Linearity, Precision, LOD, LOQ

Introduction

Amoxapine [2-Chloro-11-(piperazin-1-yl) dibenzo[b,f][1,4] oxazepane] is a tricyclic dibenzoxazepine derivative, has an antidepressant action. It is a sparse golden yellow crystalline powder, nearly insoluble in water, but soluble in organic solvents, such as chloroform and methanol[1]. Amoxapine became notable due to the fact that it could treat depressive and psychotic symptoms making it unique to tricyclic antidepressants [2].

Figure 1: Structure of Amoxapine

The molecule has a tricyclic backbone and a piperazine ring, which helps it to be dibasic with pKa of about 8.7 and 3.9 at 25 °C[3]. Amoxapine is a BCS class II and possesses a half-life of 8h. It has moderate oral bioavailability (36%) due to low water solubility, high first-pass effect, and high protein binding (90%)[4]. In this study, we describe a simple and reproducible UV-HPLC method for the quantification of pure Amoxapine that is rapid, cost-effective, and suitable for routine analysis of pharmaceutical formulations and raw materials.

2. MATERIAL AND METHODS

2.1 Materials

Amoxapine was obtained as a gift sample from Almon Healthcare (Ahmedabad, India). Methanol (HPLC Grade) was procured from Rankem Chemicals (Thane, India). Double-distilled water was freshly prepared in the laboratory using standard distillation procedures. Disodium hydrogen phosphate, potassium dihydrogen phosphate, and sodium chloride were purchased from Astron Chemicals (Ahmedabad, India).

A digital analytical balance was used (Shimadzu, Japan). pH measurements were performed using a pH meter (Lab India Instruments). Centrifugation was performed using a C-24 Plus centrifuge (Remi Instruments, Mumbai). UV absorbance measurements were conducted using a double beam UV-Visible spectrophotometer (Model: UV-1900, Shimadzu, Japan). High-Performance Liquid Chromatography (HPLC) analysis was performed using a Vanquish Core system from Thermo Fisher Scientific, Massachusetts, USA.

2.2 UV Spectrophotometric Method

2.2.1 Development of Spectrophotometric Method

2.2.1.1 Preparation of Stock Solution

Accurately weighed 10 mg Amoxapine was transferred to a 10 mL volumetric flask. Methanol (3–4 mL) was added to the above flask, the drug was dissolved properly and the final volume was made up to 10 mL with methanol to produce a stock solution of 1000 µg/mL.

2.2.1.2 Determination of λmax

1 mL from the stock solution (1000 µg/mL) was further diluted with 100 mL to produce 10 µg/mL. The spectrum of the resultant solution (10 µg/mL) was recorded in the range of 200-400 nm against methanol as a blank.

2.2.1.3 Calibration plot of Amoxapine in methanol

From the Stock solution, suitable dilutions were made to produce standard solutions of 4, 8, 12,16,20, and 24 µg/mL. The absorbance of the solutions was measured spectrophotometrically at 252 nm using methanol as a blank.

2.2.2 Validation of Spectrophotometric Method

Linearity and Range: The linear curve of the Amoxapine was obtained by plotting calibration curves with reference to standard drug solutions. Working range was determined as the lowermost/highest points of the calibration, which was determined by the analysis of the linear regression[5].

Accuracy: The validation with the developed method will run using standard addition method at three concentrations, 80%, 100%, and 120%. Weighing known amounts of pure drug into pre-analysis sample bottles, we calculated percentage recovery as a measure of the proximity of obtained values to actual concentration.

Precision: Precision is the replicability of the procedure. This was assessed by analysis of three replicate samples of the same working solution. Intra-day and inter-day variations were used to prove the precision of the method.

Intra-day Precision: It was determined by analyzing the 8,12,16 µg/mL of Amoxapine for three different times in the same day.

Inter-day Precision: It was determined by measuring the 8,12,16 µg/mL of Amoxapine for three consecutive days.

LOD and LOQ: Detection limit and quantitation limit were achieved on the basis of standard deviation of y intercepts of calibration curves and the average slope of calibration curves.

LOD = 3.3 × Standard deviation of intercept/Slope

LOQ = 10 × Standard deviation of intercept/Slope

Ruggedness: Ruggedness refers to the reproducibility of test results under expected laboratory conditions, taking into account variations such as different instruments and different analysts[6].

2.3 Chromatographic Method

2.3.1 Development of Chromatographic method

2.3.1.1 Chromatographic Conditions

The HPLC system consisted of UV-Visible Detector. The wavelength of detection set at 240nm. Separation was carried out on Endurus C18 Classic (100 × 4.6 mm, 3 µm) using 10 mM Ammonium acetate in channel A and Acetonitrile in channel B (1:1) as mobile phase with gradient elution at a flow rate of 1.5 mL/min. The mobile phase filtered through vacuum filtration and degassed with ultrasonicator prior to use. Chromatography was carried out at ambient temperature.

2.3.1.2 Standard & Sample Preparation:

Accurately weighed 10 mg of Amoxapine was transferred into a 10 mL volumetric flask and dissolved in 10 mM Ammonium acetate and Acetonitrile (1:1) to prepare a primary stock solution of 1000 µg/mL (1 mg/mL). From this stock, 1 mL was further diluted to 10 mL with 10 mM Ammonium acetate and Acetonitrile (1:1) to obtain a secondary stock solution of 100 µg/mL. Subsequent working standard concentrations (0.5, 1, 1.5, 2 and 2.5 µg/mL) required for calibration were also prepared by further diluting the secondary stock with 10 mM Ammonium acetate and Acetonitrile (1:1).

2.3.1.3 Injection sequence:

Separately injected (Prefiltered thorough syringe filter) 20 µL each of one diluent sample into the liquid chromatography, recorded the chromatograms and measured the responses for all peaks including the peaks of blank.

2.4 Validation of HPLC Method:[7, 8]

Linearity: The linearity of the analytical method for Amoxapine was determined by studying standard calibration curves. The range of the analytical method was decided from the interval between the upper and lower level of the calibration curves.

Accuracy: Accuracy of the method was assessed by standard addition method at three different concentration levels i.e. 50%, 100%, 150%. Standard concentration of 0.5,1, and 1.5 µg/mL was added into 1 µg/mL of drug concentration. The % Recoveries was calculated by applying regression equation.

Intra-day Precision: It was determined by analysing the standard solutions of Amoxapine (0.5,1.0,1.5 µg/mL) and at three different time intervals on same day.

Inter-day Precision: It was determined by analysing the combined standard solution of Amoxapine (0.5,1.0,1.5 µg/mL) on three consecutive days. The results were reported in terms of % RSD.

LOD and LOQ: The limit of detection and the limit of quantification were determined as a function of the standard deviation of the intersections and the average slope of the calibration curves.

Robustness: Stand ard solution of Amoxapine (1.5 µg/mL)) were used and analysed at different flow rate (1.2,1.5,1.7 mL/min) and wavelength (242,238,240 nm).

Ruggedness: It was verified by two different analysts maintaining the same environmental and experimental conditions. An appropriate concentration of 1.5 µg/mL Amoxapine was tested and the concentration determined.

System Suitability: Amoxapine standard solution (1.5 µg/mL) was prepared and analysed. Chromatograms for different parameters such as tailing factor, resolution and theoretical plates were studied to see whether or not they meet the recommended limit.

3. RESULT AND DISCUSSION

3.1 UV-Visible Spectrophotometric Method

3.1.1 Linearity study

To assess the linearity of the method, standard solutions of Amoxapine, ranging from 4 to 24 µg/mL, were prepared from the stock solution.

Figure 2: UV spectra of the methanolic solution of Amoxapine showing maximum absorption at λmax = 252.00 nm.

Figure 3:  Calibration plot of Amoxapine in methanol

Table 1: Calibration data of Amoxapine in methanol

Concentration (μg/mL)

Absorbance (Mean± SD)

%RSD

0

0

0

4

0.149±0.001

0.671

8

0.302±0.003

0.993

12

0.465±0.002

0.568

16

0.641±0.002

0.392

20

0.768±0.003

0.397

24

0.921±0.005

0.604

Table 2: Linear regression analysis by UV

Sr. No.

Parameters

Result

1

λmax (nm)

252

2

Beer's law limit (μg/mL)

4-24

3

Regression equation[y]

y = 0.0387x - 0.0012

4

Slope[m]

0.0387

5

Intercept [c]

-0.0012

6

Correlation coefficient []

0.999

7

Limit of detection (LOD) (μg/mL)

0.252(µg/mL)

8

Limit of quantification (LOQ) (μg/mL)

0.765 (µg/mL)

3.1.2 Validation Parameters:

Method validation was performed according to ICH guidelines. The Accuracy of the method was determined at the 50%, 100% and 150% level by the standard addition method and the precision of the method was determined by the % RSD of intraday precision, interday precision [9, 10].

Table 3: Result of Accuracy study

Concentrations (μg/mL)

Level

Absorbance

Obtain Concentration (μg/mL)

%Recovery

12.8

80%

0.472

12.355

96.526

16

100%

0.644

16.917

105.736

19.2

120%

0.734

19.305

100.547

Table 4: Result of intra-day precision

Concentration(μg/mL)

Absorbance

Mean

SD

% RSD

 

(10:00am)

(12:00pm)

(2:00pm)

 

 

 

8

0.293

0.291

0.296

0.293

0.002

0.293

12

0.452

0.458

0.455

0.455

0.003

0.455

16

0.648

0.652

0.654

0.651

0.003

0.651

Table 5: Result of inter-day precision

Concentration(μg/mL)

Absorbance

Mean

SD

%RSD

 

Day 1

Day 2

Day 3

 

 

 

8

0.286

0.284

0.287

0.285

0.001

0.285

12

0.454

0.457

0.459

0.456

0.002

0.456

16

0.647

0.652

0.657

0.652

0.005

0.652

Table 6:  Result of robustness study

Concentration (μg/mL)

Absorbance at 254 nm

Absorbance at 253nm

Absorbance at 251nm

Absorbance at 250nm

8

0.289

0.291

0.290

0.288

12

0.448

0.451

0.450

0.449

16

0.640

0.643

0.645

0.642

Table 7: Result of ruggedness study

Concentration (µg/mL)

Analyst 1

Analyst 2

Mean

SD

%RSD

8

0.295

0.292

0.293

0.002

0.722

12

0.458

0.453

0.455

0.003

0.776

16

0.647

0.649

0.648

0.001

0.218

Table 8: Specificity study

Concentration (µg/mL)

Absorbance

Absorbance with (2% DMSO)

8

0.291

0.285

12

0.453

0.459

16

0.641

0.637

3.2 Chromatographic Method

3.2.1 Selection of Analytical Wavelength:

Amoxapine standard solutions (10 µg/mL) were scanned in the UV region of 200-400 nm and spectra were recorded. Amoxapine were observed to show absorbance at 240 nm. So, the detection wavelength used was 240 nm.

3.2.2 Optimized Parameter (Gradient HPLC):

Mobile phase

A: 10 mM Ammonium acetate

B: Acetonitrile

Selection of column

Endurus C18 Classic (100 × 4.6 mm, 3 µm)

Injection volume

20 µL

Flow rate

1.5 mL/min

Column temperature

Ambient Temperature

Detection wavelength

240 nm

Retention time

4.162 min

Figure 4: Chromatograph of Amoxapine by HPLC

3.2.3 Linearity Study:

Amoxapine was found to be linear in the concentration range of 0.5-2.5 µg/mL.

Figure 5: HPLC chromatograms of Amoxapine (0.5–2.5 µg/mL) showing retention at 4.162 min with concentration-dependent peak response.

Figure 6: Calibration curve of Amoxapine by HPLC

Table 8: Specificity study

Concentration (µg/mL)

Absorbance

Absorbance with

(2% DMSO)

8

0.291

0.285

12

0.453

0.459

16

0.641

0.637

Table 9: Result of calibration curve

Sr. No.

Concentration (μg/mL)

Area (μAU*sec)

1

0.5

20289

2

1

42379

3

1.5

64848

4

2

86600

5

2.5

110614

Table 10: Summary of method validation parameter

Sr. No.

Parameters

Values

1

λmax (nm)

240

2

Beer's law limit (μg/mL)

0.5-2.5

3

Regression equation[y]

y = 44974x - 2515.3

4

Slope[m]

44974

5

Intercept [c]

2515.3

6

Correlation coefficient [R²]

0.9997

7

Limit of detection (LOD) (μg/mL)

0.048

8

Limit of quantitation (LOQ) (μg/mL)

0.146

3.2.4 Validation Parameters:

This method was validated according to the ICH guidelines. The percentage of recoveries of Amoxapine was found in the range of 99.97 to 100.4%. The precision of the method was determined by the % RSD. The LOD and LOQ of Amoxapine were found to be 0.048 and 0.146 µg /mL, respectively. For the robustness study, the effect of the change in wavelength and flow rate on the mean peak area, % RSD and % assay was studied. The percentage of RSD of each peak in all variables was found to be less than 2% [11, 12].

Accuracy

Accuracy was studied by standard addition method and % recovery found was within acceptable limit.

Table 11: Result of Accuracy by HPLC

Level of addition

Theoretical total (µg/mL)

Area (μAU*sec)

Found (µg/mL)

% recovery

SD

% RSD

50%

1.5

64848

1.4978

99.855%

0.772%

0.773%

100%

2

86600

1.9815

99.074%

150%

2.5

110614

2.5154

100.617%

Mean % Recovery: 99.849%

Precision

Intra-day and inter-day precision assures the repeatability of test results. The % RSD found was below 2.

Table 12A: Result of intraday precision

Sr. No

Concentration (μg/mL)

Area

(μAU*sec)

Mean

(μAU*sec)

SD

%RSD

1

0.5

20,250

 

20,283

 

30.45

 

0.15%

2

0.5

20,289

3

0.5

20,310

4

1

42,300

 

42,376.33

 

75.04

 

0.18%

5

1

42,379

6

1

42,450

7

1.5

64,750

 

64,839.33

 

85.33

 

0.13%

8

1.5

64,848

9

1.5

64,920

Table 12B: Result of Interday precision

Sr. No

Concentration (μg/mL)

Area (μAU*sec)

Mean

(μAU*sec)

SD

%RSD

1

0.5

20,240

 

20,281.33

 

38.14

 

0.19%

2

0.5

20,289

3

0.5

20,315

4

1

42,350

 

42,383.00

 

35.12

 

0.08%

5

1

42,379

6

1

42,420

7

1.5

64,790

 

64,846.00

 

55.08

 

0.09%

8

1.5

64,848

9

1.5

64,900

Robustness

Robustness was studied by different deliberate variations in the chromatographic conditions.

Table 13: Result of robustness study

Sr. No

Parameter

Condition

Area (μAU*sec)

Mean

(μAU*sec)

SD

%RSD

1

Change in Flow rate (ml/min)

1.2

65,050

 

64832.66

 

225.41

 

0.35 %

 

2

1.5

64,848

3

1.7

64,600

1

Change in Wavelength (nm)

238

64,750

 

64849.33

 

100.01

 

0.15 %

2

240

64,848

3

242

64,950

Ruggedness

Ruggedness was studied by different analyst.

Table 14: Result of Ruggedness

Sr. No

Analyst

Concentration (μg/mL)

Area (μAU*sec)

Mean

(μAU*sec)

SD

% RSD

1

1

1.5

64,750

64900

212.13

0.33%

2

2

1.5

65,050

Specificity

Excipients and impurities were not interacting with the standard drug; hence method is specific.

Table 15: Data for specificity study

Sr. No

Analyst

Concentration (μg/mL)

Area (μAU*sec)

Mean

(μAU*sec)

SD

% RSD

1

1

1.5

64,750

64900

212.13

0.33%

2

2

1.5

65,050

Table 16: Result of system Suitability

Sr. No

Concentration

(μg/ml)

Retention Time

(Min)

Theoretical plates

Asymmetry Factor

1

1.5

4.162

5230

1.08

2

1.5

4.158

5225

1.07

3

1.5

4.166

5220

1.09

4

1.5

4.160

5235

1.08

5

1.5

4.165

5228

1.07

6

1.5

4.159

5222

1.08

Mean

 

4.1617

5226.67

1.078

SD

 

0.0029

5.16

0.008

%RSD

 

0.07%

0.099%

0.74%

CONCLUSION

A simple, sensitive, and validated UV spectrophotometric method and HPLC method were successfully developed for the quantitative determination of Amoxapine in bulk dosage form. Amoxapine showed maximum absorbance at 252 nm in methanol with a linear range of 4–24 μg/mL (R² = 0.999), while the HPLC method demonstrated excellent linearity in the range of 0.5–2.5 μg/mL (R² = 0.9997) with a retention time of 4.162 min. Both methods exhibited good precision (%RSD < 2) and accuracy within ICH acceptance limits. No significant interference was observed from excipients or impurities. Thus, the developed methods are simple, accurate, and precise, and can be reliably applied for routine analysis, stability studies, and quality control of Amoxapine in pharmaceutical formulations.

ABBREVIATIONS

  • HPLC: High Performance Liquid Chromatography
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • SD: Standard Deviation
  • RSD: Relative Standard Deviation

ACKNOWLEDGEMENT

The authors express their sincere appreciation to Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara for the invaluable support in conducting this research. The facilities and resources provided, were instrumental in conducting the experiments and collecting the necessary data.

CONFLICT OF INTEREST

The authors declare no conflict of interest, financial or otherwise.

REFERENCES

  1. R. M. Bhardwaj, V. Raval, I. D. Oswald, and A. J. Florence, "Crystal structure of a mixed solvated form of amoxapine acetate," (in eng), Acta Crystallogr E Crystallogr Commun, vol. 71, no. Pt 2, pp. 139-41, Feb 1 2015.
  2. B. M. Cohen, P. Q. Harris, R. I. Altesman, and J. O. Cole, "Amoxapine: neuroleptic as well as antidepressant?," (in eng), Am J Psychiatry, vol. 139, no. 9, pp. 1165-1167, 1982/09// 1982.
  3. M. Joshi and A. Roy Choudhury, "Salts of Amoxapine with Improved Solubility for Enhanced Pharmaceutical Applicability," (in eng), ACS Omega, vol. 3, no. 2, pp. 2406-2416, Feb 28 2018.
  4. A. Yadav, S. Tripathi, V. Sharma, S. Soni, and D. Tiwari, "Formulation, Optimised and Evaluation of Mouth dissolving film of Amoxapine," Asian Journal of Pharmaceutical Research and Development, vol. 9, no. 1, pp. 67-70, 2021.
  5. K. B. Chaudhary, K. Bhardwaj, G. Verma, and P. Kumar, "Validated Analytical Method development for the determination of Meloxicam by UV Spectroscopy in API and Pharmaceutical dosage form," Asian J. Pharm. Educ. Res, vol. 7, pp. 60-69, 2018.
  6. B. Kumari and A. Khansili, "Analytical Method Development and Validation of UV-visible Spectrophotometric Method for the Estimation of Vildagliptin in Gastric Medium," (in eng), Drug Res (Stuttg), vol. 70, no. 9, pp. 417-423, Sep 2020.
  7. S. A. Amol Amrutkar*1, Rishikesh Bachhav3 "Development And Validation Of UV-HPLC Method For The Estimation Of Diacerein In Bulk And Tablet Dosage Form  " 2022.
  8. D. A. G. Harshita Joshi*, "Development And Validation Of UV-HPLC Method For The Estimation of Diacerein In Bulk And Tablet Dosage Form," 2025.
  9. D. M. D. Sushila Dagadu Chavan 1, "Analytical method validation: A brief review," 2022.
  10. K. H. Ashish Kumar Srivastava*, "A review article on validation & analytical method validation," 2022.
  11. S. DR. Naikwadi College of Pharmacy Jamgaon, "A Review on HPLC Method Development and Validation " 2024.
  12. M. A. K. Dhirendra Kumar Mehta*, Koiri Sonali " HPLC method development and validation: a review," 2023.

Reference

  1. R. M. Bhardwaj, V. Raval, I. D. Oswald, and A. J. Florence, "Crystal structure of a mixed solvated form of amoxapine acetate," (in eng), Acta Crystallogr E Crystallogr Commun, vol. 71, no. Pt 2, pp. 139-41, Feb 1 2015.
  2. B. M. Cohen, P. Q. Harris, R. I. Altesman, and J. O. Cole, "Amoxapine: neuroleptic as well as antidepressant?," (in eng), Am J Psychiatry, vol. 139, no. 9, pp. 1165-1167, 1982/09// 1982.
  3. M. Joshi and A. Roy Choudhury, "Salts of Amoxapine with Improved Solubility for Enhanced Pharmaceutical Applicability," (in eng), ACS Omega, vol. 3, no. 2, pp. 2406-2416, Feb 28 2018.
  4. A. Yadav, S. Tripathi, V. Sharma, S. Soni, and D. Tiwari, "Formulation, Optimised and Evaluation of Mouth dissolving film of Amoxapine," Asian Journal of Pharmaceutical Research and Development, vol. 9, no. 1, pp. 67-70, 2021.
  5. K. B. Chaudhary, K. Bhardwaj, G. Verma, and P. Kumar, "Validated Analytical Method development for the determination of Meloxicam by UV Spectroscopy in API and Pharmaceutical dosage form," Asian J. Pharm. Educ. Res, vol. 7, pp. 60-69, 2018.
  6. B. Kumari and A. Khansili, "Analytical Method Development and Validation of UV-visible Spectrophotometric Method for the Estimation of Vildagliptin in Gastric Medium," (in eng), Drug Res (Stuttg), vol. 70, no. 9, pp. 417-423, Sep 2020.
  7. S. A. Amol Amrutkar*1, Rishikesh Bachhav3 "Development And Validation Of UV-HPLC Method For The Estimation Of Diacerein In Bulk And Tablet Dosage Form  " 2022.
  8. D. A. G. Harshita Joshi*, "Development And Validation Of UV-HPLC Method For The Estimation of Diacerein In Bulk And Tablet Dosage Form," 2025.
  9. D. M. D. Sushila Dagadu Chavan 1, "Analytical method validation: A brief review," 2022.
  10. K. H. Ashish Kumar Srivastava*, "A review article on validation & analytical method validation," 2022.
  11. S. DR. Naikwadi College of Pharmacy Jamgaon, "A Review on HPLC Method Development and Validation " 2024.
  12. M. A. K. Dhirendra Kumar Mehta*, Koiri Sonali " HPLC method development and validation: a review," 2023.

Photo
Hemal Tandel
Corresponding author

The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat

Photo
Vishwa Patel
Co-author

The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat

Photo
Yash Bhimani,
Co-author

The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat

Vishwa Patel, Yash Bhimani, Hemal Tandel, Analytical Method Development and Validation of UV-HPLC Method for The Estimation of Amoxapine, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 11, 907-917. https://doi.org/10.5281/zenodo.17542724

More related articles
Review Article On Epilepsy Seizures ...
Akanksha Mahajan , Prof. Komal Chavan , Dr. Kavita kulkarni , ...
Review on Plant Nyctanthes arbortristis for Anti I...
Manisha Kasar, Mugdha Joshi, Vilasini Pandav, Sukanya Kamane, Pra...
Acalabrutinib induced headache...
S. Sai Krishna, Karthik J., Vignesh A., ...
Synthesis and Evaluation of novel N 6 nitrobenzo d thiazol 2 yl 2 acetamide as A...
Sandip. S. Chaudhari, Prashant P. Nikumbh, Rahulsing U. Khairnar, Tarannum R. Sayyad, Mayur R. Bhura...
Formulate and Evaluate Controlled Release of Rofecoxib Tablet...
Brajesh yaduraj, Shruti Rathore, Sudhir kathane, ...
Related Articles
Formulation, Development And Evaluation Of Polyherbal Wound Healing Gel ...
Omkar Salunkhe, Pranjal Chougule , Nilesh Chougule , ...
The Impact Of Artificial Intelligence On Nosocomial Infection Control: A Compreh...
Ganesh Anil Vitukade, Nishigandha S. Chopde, Monika N. Pawar, Ashwini A. Bhosale, ...
Fragrance Forensics: Decoding the Chemistry of Perfume!...
Sahil kadam, Dr. Sadhana Shahi, Shital Patil , Shahaji kumbhar , ...
A State-Of-The-Art Overview of Quinoxaline, Its Derivatives, and Applications...
Umesh Verma, Poonam Rishishwar, Sanjay Rishishwar, ...
Review Article On Epilepsy Seizures ...
Akanksha Mahajan , Prof. Komal Chavan , Dr. Kavita kulkarni , ...
More related articles
Review Article On Epilepsy Seizures ...
Akanksha Mahajan , Prof. Komal Chavan , Dr. Kavita kulkarni , ...
Review on Plant Nyctanthes arbortristis for Anti Inflammatory Activity...
Manisha Kasar, Mugdha Joshi, Vilasini Pandav, Sukanya Kamane, Prajwal Nimkarde, ...
Acalabrutinib induced headache...
S. Sai Krishna, Karthik J., Vignesh A., ...
Review Article On Epilepsy Seizures ...
Akanksha Mahajan , Prof. Komal Chavan , Dr. Kavita kulkarni , ...
Review on Plant Nyctanthes arbortristis for Anti Inflammatory Activity...
Manisha Kasar, Mugdha Joshi, Vilasini Pandav, Sukanya Kamane, Prajwal Nimkarde, ...
Acalabrutinib induced headache...
S. Sai Krishna, Karthik J., Vignesh A., ...